CIK 0001651308 · Large accelerated filer
BeOne Medicines Ltd.
Sign in to watch- Ticker
- BEIGF
- Exchange
- Nasdaq, OTC
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- operating
- EIN
- 981209416
- Phone
- 41-616851900
- Business address
- C/O BEONE MEDICINES I GMBH, AESCHENGRABEN 27, 21ST FLOOR, BASEL, Switzerland, 4051
- Former names
- BeiGene, Ltd.
Securities
- ONC American Depositary Shares Nasdaq
- BEIGF Common stock OTC
- 144 Insider Sale of Securities
- 4 Open-market sale Director sold 2,665 shares at $337.00 ($898,105)
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 4 Open-market sale Principal Accounting Officer sold 122 shares at $326.76 ($39,865)
- 144 Insider Sale of Securities
- 8-K Event Results of operations
- 8-K Event Material agreement · New debt or obligation · Regulation FD disclosure
- 4 Planned sale President and COO sold 89,794 shares at an average $304.56 ($27,347,635)
- 4 Planned sale SVP, General Counsel sold 11,013 shares at an average $300.45 ($3,308,877)
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- 4 Open-market sale Chief Financial Officer sold 1,190 shares at $290.47 ($345,659)
- 144 Insider Sale of Securities
- 4 Planned sale Global Head of R&D sold 4,300 shares at an average $302.65 ($1,301,375)
- 4 Open-market sale SVP, General Counsel sold 920 shares at $304.60 ($280,233)
- 144 Insider Sale of Securities
- 4 Planned sale Global Head of R&D sold 700 shares at $300.00 ($210,000)
Page 9 of 64 · 1,278 filings